NDC 80425-0316-01 - Doxepin Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0316
- Requested NDC
- 80425-0316-01
- Package NDCs from labels
- 80425-0316-1, 80425-0316-2, 80425-0316-3, 80425-0316-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxepin Hydrochloride - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0316-1 | Doxepin Hydrochloride | 30 in 1 BOTTLE | CAPSULE | 30 | 2 | |
| 80425-0316-2 | Doxepin Hydrochloride | 60 in 1 BOTTLE | CAPSULE | 60 | 2 | |
| 80425-0316-3 | Doxepin Hydrochloride | 90 in 1 BOTTLE | CAPSULE | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0316 | DOXEPIN HYDROCHLORIDE CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f900bac4-02f2-6bf3-e053-6394a90a2161.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0316-1 | EA - Each | 80425-0316 | 28464baa-062f-4d04-b030-cd4f5b80a754 | 1 | 2023-06-06 |
| 80425-0316-2 | EA - Each | 80425-0316 | 7bca9d58-efc4-4209-8a21-2693fc3e32f3 | 1 | 2023-06-06 |
| 80425-0316-3 | EA - Each | 80425-0316 | f2b33fc2-fff3-4425-b00a-1fb444945861 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | NorthStar RxLLC | 03cef3a6-a63d-4082-a491-451b24227d9d | 2025-09-14 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Major Pharmaceuticals | df3b6be0-6a64-4174-b351-dab2061f290e | 2025-09-10 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 89ed6385-cf6a-458e-81ea-c7f3fead41c5 | 2025-09-09 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Aurobindo Pharma Limited | f3c242dd-426e-4c69-8f21-2645361d5f27 | 2025-09-01 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| doxepin hydrochloride | DOXEPIN HYDROCHLORIDE | Sun Pharmaceutical Industries, Inc. | 554ab06f-6420-42b3-89d1-d97554c237d8 | 2025-08-06 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Lifestar Pharma LLC | fdaf3bd7-c456-40bd-8bc3-2b67eb1846c8 | 2025-08-01 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin HCL | DOXEPIN HCL | Direct_Rx | 3a870ceb-5a95-9351-e063-6294a90a3027 | 2025-07-22 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Mylan Institutional Inc. | 137a953b-3c48-405f-86a6-ff778cb7f5f2 | 2025-07-18 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 4920401a-cde5-404b-82aa-c3c0e8911065 | 2025-07-17 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin | DOXEPIN HYDROCHLORIDE | Bryant Ranch Prepack | 207bb11e-6029-4506-92d2-2d8a776b9408 | 2025-05-02 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin | DOXEPIN HYDROCHLORIDE | Bryant Ranch Prepack | bc3b0401-df4a-46a2-a29b-3d70e72aa88b | 2025-05-01 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin hydrochloride | DOXEPIN HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 66c6af99-9909-4b18-a43b-898a1c4a34d7 | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin | DOXEPIN HYDROCHLORIDE | Strides Pharma Science Limited | 399866d5-3fa6-46d0-9c62-492d5997bc4f | 2025-03-21 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Bryant Ranch Prepack | 3bc72772-22ae-4f29-97ff-4a552b4df6d0 | 2025-01-28 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | Bryant Ranch Prepack | 06e027bb-516d-4a1d-b5a0-a66c051eb367 | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin HCL | DOXEPIN HCL | Direct_Rx | dea965fe-6b54-bbf0-e053-2a95a90a1003 | 2025-01-22 | Warnings, Adverse reactions | ANDA213063 3U9A0FE9N5 |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | direct rx | b56cdaee-6187-c763-e053-2995a90acc3f | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | ANDA213063 1000070 3U9A0FE9N5 |
| doxepin | DOXEPIN | Zydus Lifesciences Limited | 1461ede6-24f0-42a1-b801-0cf4ef404985 | 2025-01-08 | 3U9A0FE9N5 | |
| doxepin | DOXEPIN | Viona Pharmaceuticals Inc | 3377541d-db46-4fd9-9a4b-faa5f6108e67 | 2025-01-08 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 2bf7d838-6274-4d8a-91cb-b27e1e81d273 | 2025-01-03 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.